Latham & Watkins Represents PHC Holdings Corporation and Ascensia Diabetes Care in Exclusive Global Commercial Agreement with Senseonics and Related Financing

Bicoastal team advised the global healthcare company on the distribution and financing agreements.

August 13, 2020

PHC Holdings Corporation and Ascensia Diabetes Care, a PHC Group company, has announced a strategic partnership with Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. The partnership comprises a global commercialization and distribution agreement and a concurrent financing agreement. As part of the financing agreement, PHC Holdings Corporation, the parent company of Ascensia, has made an initial strategic investment of US$35 million into Senseonics in the form of convertible debt securities. In addition, a further US$15 million investment will be provided in exchange for Senseonics convertible preferred equity, upon FDA approval of the 180-day Eversense product.

Latham & Watkins LLP represented PHC Holdings Corporation in the distribution agreement and financing agreement. Partner Judith Hasko and associate Peggy Ni advised on the distribution agreement, and partners Greg Rodgers and Paul Bonewitz advised on the financing, with associates Andrew Blumenthal, Preeta Paragash, Nicholas Reist, Claire Solimine, and Matthew Issa. Advice was also provided on tax matters in the financing by partner Bora Bozkurt, with associate Aaron Bernstein. Partner Josh Dubofsky advised on general corporate matters on all aspects of the transactions.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.